333 related articles for article (PubMed ID: 6311897)
1. Evidence for a nonoxidative mechanism of human natural killer (NK) cell cytotoxicity by using mononuclear effector cells from healthy donors and from patients with chronic granulomatous disease.
Kay HD; Smith DL; Sullivan G; Mandell GL; Donowitz GR
J Immunol; 1983 Oct; 131(4):1784-8. PubMed ID: 6311897
[TBL] [Abstract][Full Text] [Related]
2. Compared mechanisms of tumor cytolysis by human natural killer cells and activated polymorphonuclear leukocytes.
Abrams SI; Brahmi Z
J Immunol; 1984 Jun; 132(6):3192-6. PubMed ID: 6327820
[TBL] [Abstract][Full Text] [Related]
3. Lysis of tumor cells by human blood monocytes by a mechanism independent of activation of the oxidative burst.
Kleinerman ES; Ceccorulli LM; Bonvini E; Zicht R; Gallin JI
Cancer Res; 1985 May; 45(5):2058-64. PubMed ID: 2985242
[TBL] [Abstract][Full Text] [Related]
4. Impaired oxidative burst does not affect human monocyte tumoricidal activity.
Chen AR; Koren HS
J Immunol; 1985 Mar; 134(3):1909-13. PubMed ID: 2981928
[TBL] [Abstract][Full Text] [Related]
5. The chemiluminescence response of human natural killer cells. II. Association of a decreased response with low natural killer activity.
Werkmeister J; Helfand S; Roder J; Pross H
Eur J Immunol; 1983 Jun; 13(6):514-20. PubMed ID: 6574914
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity by human adherent cells: oxygen-dependent and -independent cytotoxic reactions by different cell populations.
van Kessel KP; Visser MR; van Strijp JA; van Kats-Renaud JH; Verhoef J
Immunology; 1986 Jun; 58(2):291-6. PubMed ID: 3710525
[TBL] [Abstract][Full Text] [Related]
7. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
Colotta F; Peri G; Villa A; Mantovani A
J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
[TBL] [Abstract][Full Text] [Related]
8. Anti-C-reactive protein inhibits cytoskeletal rearrangement without altering calcium influx in natural killer cell activation.
Khattri R; Hansen B; Nichols TC; Palmer KL; Gilman-Sachs A; Baum LL
Cell Immunol; 1994 May; 155(2):457-75. PubMed ID: 8181076
[TBL] [Abstract][Full Text] [Related]
9. Monocyte-mediated augmentation of human natural killer cell activity: conditions, monocyte and effector cell characteristics.
Bloom ET; Babbitt JT; Kawakami K
J Immunol; 1986 Jul; 137(1):172-8. PubMed ID: 3711665
[TBL] [Abstract][Full Text] [Related]
10. Tumor-activated NK cells trigger monocyte oxidative metabolism.
Pohajdak B; Gomez JL; Wilkins JA; Greenberg AH
J Immunol; 1984 Nov; 133(5):2430-6. PubMed ID: 6434630
[TBL] [Abstract][Full Text] [Related]
11. Dissociation of responses measured by natural cytotoxicity and chemiluminescence.
Ernst M; Lange A; Flad HD; Havel A; Ennen J; Ulmer AJ
Eur J Immunol; 1984 Jul; 14(7):634-9. PubMed ID: 6430710
[TBL] [Abstract][Full Text] [Related]
12. Histaminergic regulation of NK cells. Role of monocyte-derived reactive oxygen metabolites.
Hellstrand K; Asea A; Dahlgren C; Hermodsson S
J Immunol; 1994 Dec; 153(11):4940-7. PubMed ID: 7963557
[TBL] [Abstract][Full Text] [Related]
13. The human promyelocytic HL60 cell line: a model of myeloid cell differentiation using dimethylsulphoxide, phorbol ester and butyrate.
Ahmed N; Williams JF; Weidemann MJ
Biochem Int; 1991 Feb; 23(3):591-602. PubMed ID: 1652248
[TBL] [Abstract][Full Text] [Related]
14. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
Burns GF; Triglia T; Werkmeister JA
J Immunol; 1984 Sep; 133(3):1656-63. PubMed ID: 6611374
[TBL] [Abstract][Full Text] [Related]
15. Natural, lectin- and phorbol ester-induced cellular cytotoxicity in Crohn's disease and ulcerative colitis.
Aparicio-Pagés MN; Verspaget HW; Peña AS; Weterman IT; Mieremet-Ooms MA; van der Zon JM; de Bruin PA; Lamers CB
J Clin Lab Immunol; 1988 Nov; 27(3):109-13. PubMed ID: 3246686
[TBL] [Abstract][Full Text] [Related]
16. Involvement of hydroxyl free radical, but not superoxide, in the cytolytic pathway of natural killer cells. Revision of an earlier hypothesis.
Duwe AK; Roder JC
Med Biol; 1984; 62(2):95-100. PubMed ID: 6088913
[TBL] [Abstract][Full Text] [Related]
17. Depressed polymorphonuclear leukocyte functions associated with normal cytotoxic functions of T and natural killer cells during chronic hemodialysis.
Charpentier B; Lang P; Martin B; Noury J; Mathieu D; Fries D
Clin Nephrol; 1983 Jun; 19(6):288-94. PubMed ID: 6603319
[TBL] [Abstract][Full Text] [Related]
18. Generation of suppressor cells for natural killer activity in cancer patients after surgery.
Uchida A; Kolb R; Micksche M
J Natl Cancer Inst; 1982 May; 68(5):735-41. PubMed ID: 6461792
[TBL] [Abstract][Full Text] [Related]
19. Regulation of monocyte oxidative metabolism: chemotactic factor enhancement of superoxide release, hydroxyl radical generation, and chemiluminescence.
Janco RL; English D
J Lab Clin Med; 1983 Dec; 102(6):890-8. PubMed ID: 6315837
[TBL] [Abstract][Full Text] [Related]
20. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S
J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
